lyphomed inc said intends file registration statement with securities and exchange commission covering sale mln dlrs principal amount convertible subordinated debentures concurrent with debenture offering lyphomed said plans sell additional mln dlrs debentures fujisawa pharmaceutical ltd which currently owns about pct company common stock said offering will made only prospectus reuter 